Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.

Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study. Biol Blood Marrow Transplant. 2006 Jul; 12(7):778-85.

View in: PubMed

subject areas

Adult
Carcinoma, Renal Cell
Female
Graft vs Host Disease
Graft vs Tumor Effect
Humans
Immunotherapy, Adoptive
Kidney Neoplasms
Male
Middle Aged
Stem Cell Transplantation
Survival Analysis

authors with profiles

Walter M. Stadler